1-p-Anisyl-2,3-dimethylbutan | 29143-10-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-p-Anisyl-2,3-dimethylbutan
• 英文别名: 1-(2,3-Dimethylbutyl)-4-methoxybenzene
• CAS: 29143-10-0
• 化学式: C₁₃H₂₀O
• 分子量: 192.301
• InChiKey: YMYAMSRZUNSDIA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] CORTICOSTEROID LINKED BETA-AGONIST COMPOUNDS FOR USE IN THERAPY<br/>[FR] COMPOSÉS BÊTA-AGONISTES LIÉS À DES CORTICOSTÉROÏDES POUR UNE UTILISATION EN THÉRAPIE
  申请人：GILEAD SCIENCES INC

  公开号：WO2010126953A1

  公开（公告）日：2010-11-04

  New chemical entities which comprise corticosteroids and phosphorylated β- agonists for use in therapy and compositions comprising and processes for preparing the same are provided.

  新的化学实体包括皮质类固醇和磷酸化的β-激动剂，用于治疗以及包含它们的组合物和制备这些化学实体的方法。
• [EN] CORTICOSTEROID BETA-AGONIST COMPOUNDS FOR USE IN THERAPY<br/>[FR] COMPOSÉS DE ?-AGONISTES ET DE CORTICOSTÉROÏDES DESTINÉS À ÊTRE UTILISÉS EN THÉRAPIE
  申请人：GILEAD SCIENCES INC

  公开号：WO2010132743A1

  公开（公告）日：2010-11-18

  New chemical entities which comprise corticosteroids and phosphorylated β-agonists for use in therapy and compositions comprising and processes for preparing the same are provided.

  提供了用于治疗的包含皮质类固醇和磷酸化β-激动剂的新化学实体，以及包含和制备这些化学实体的组合物和过程。
• MATERIALS WITH IMPROVED PROPERTIES
  申请人：Massachusetts Institute of Technology

  公开号：US20170246347A1

  公开（公告）日：2017-08-31

  Products, such as devices, prostheses, and materials, whose surfaces have been modified in order to impart beneficial properties to these products are disclosed. The surface-modified products have improved biocompatibility compared to a corresponding product that lacks the modification. Following implantation in a subject, the surface-modified products induce a lower foreign-body response, compared to a corresponding unmodified product.
• THIENO- AND PYRROLOPYRIMIDINE ANALOGUES AND PRODRUGS THEREOF AS ANTICANCER AGENTS AND METHODS OF USE THEREOF
  申请人：UNIVERSITY OF MARYLAND, BALTIMORE COUNTY

  公开号：US20190160071A1

  公开（公告）日：2019-05-30

  The present invention provides for the design and synthesis of halogenated thieno- and pyrrolopyrimidine compounds and prodrugs thereof that exhibit cancer proliferation inhibitory activity and the use thereof for cancer treatment.
• [EN] CORTICOSTEROID LINKED BETA-AGONIST COMPOUNDS FOR USE IN THERAPY<br/>[FR] COMPOSÉS BÊTA AGONISTES LIÉS À DES CORTICOSTÉROÏDES EN VUE D'UNE UTILISATION EN THÉRAPIE
  申请人：GILEAD SCIENCES INC

  公开号：WO2009152171A1

  公开（公告）日：2009-12-17

  New chemical entities which comprise corticosteroids and phosphorylated β-agonists for use in therapy and compositions comprising and processes for preparing the same.